| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RGNX over the last quarter tilts toward buying: insiders added a net 102,603 shares worth roughly $949K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $3.78M | - | |
| CEO | 338.1K | $2.58M | - | |
| Other | 240.7K | $1.84M | - | |
| Other | 240.3K | $1.83M | - | |
| CFO | 147.1K | $1.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2017 | Stephen Yoo | Chief Medical Officer | Sale+OE | 15,000 | $20.03 | $300,450.00 | - | |
| Aug 21, 2017 | Kenneth T. Mills81 | President and CEO | Sell | 6,500 | $20.05 | $130,325.00 | -5.8% | |
| Aug 15, 2017 | Vittal Vasista79 | Chief Financial Officer | Sell | 3,040 | $21.09 | $64,110.85 | -2.9% | |
| Jul 20, 2017 | Stephen Yoo | Chief Medical Officer | Sale+OE | 15,000 | $18.66 | $279,900.00 | - | |
| Jul 20, 2017 | Kenneth T. Mills81 | President and CEO | Sell | 6,500 | $18.66 | $121,290.00 | -5.5% | |
| Jul 17, 2017 | Vittal Vasista79 | Chief Financial Officer | Sell | 3,100 | $19.81 | $61,411.00 | -2.9% | |
| Jun 20, 2017 | Stephen Yoo | Chief Medical Officer | Sale+OE | 15,000 | $19.68 | $295,157.00 | - | |
| Jun 20, 2017 | Kenneth T. Mills81 | President and CEO | Sell | 6,500 | $19.68 | $127,901.76 | -5.2% | |
| Jun 15, 2017 | Vittal Vasista79 | Chief Financial Officer | Sell | 3,100 | $18.75 | $58,125.00 | -2.8% | |
| May 15, 2017 | Donald J Hayden Jr. | Director | Sell | 8,599 | $19.04 | $163,724.96 | -100% |